Alehagen U, Alexander J, Aaseth J, Larsson A, Svensson E, Opstad T. Effects of an Intervention with Selenium and Coenzyme Q10 on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled . Cells. 2023;12: pubmed publisher

Altuna Coy A, Ruíz Plazas X, Alves Santiago M, Segarra Tomás J, Chacon M. Serum Levels of the Cytokine TWEAK Are Associated with Metabolic Status in Patients with Prostate Cancer and Modulate Cancer Cell Lipid Metabolism In Vitro. Cancers (Basel). 2021;13: pubmed publisher

Piantoni S, Regola F, Masneri S, Merletti M, Lowin T, Airo P, et al. Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Beli. Front Pharmacol. 2021;12:666971 pubmed publisher

Ruíz Plazas X, Altuna Coy A, Alves Santiago M, Vila Barja J, García Fontgivell J, Martínez González S, et al. Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness. Cancers (Basel). 2021;13: pubmed publisher

Wang H, Wang S, Li L, Wang X, Liu C, Lu M, et al. Involvement of the cytokine TWEAK in the pathogenesis of psoriasis vulgaris, pustular psoriasis, and erythrodermic psoriasis. Cytokine. 2021;138:155391 pubmed publisher

Ruíz Plazas X, Rodríguez Gallego E, Alves M, Altuna Coy A, Lozano Bartolomé J, Portero Otín M, et al. Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness. J Transl Med. 2019;17:307 pubmed publisher

Dereke J, Nilsson J, Nilsson C, Strevens H, Landin Olsson M, Hillman M. Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance. PLoS ONE. 2019;14:e0216728 pubmed publisher

Keshtkar Jahromi M, Ouyang M, Keshtkarjahromi M, Almed S, Li H, Walston J, et al. Effect of influenza vaccine on tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in older adults. Vaccine. 2018;36:2220-2225 pubmed publisher

Hwang I, Youm Y, Cho S, Choi S, Bae M, Park S, et al. Synovial fluid levels of TWEAK and matrix metalloproteinase 1 in patients with osteoarthritis, and associations with disease severity. J Orthop Surg (Hong Kong). 2018;26:2309499018760112 pubmed publisher

Alwahaibi N, Alissaei H, Al Kalbani A, Alabri N, Allawati Z, Albalooshi M. Evaluation of interleukin-2, interleukin-8, and tumor necrosis factor-like weak inducer of apoptosis in hemodialysis and renal transplant patients and healthy controls. Saudi J Kidney Dis Transpl. 2016;27:1123-1128 pubmed

Sasaki Y, Shimizu Y, Suzuki Y, Horikoshi S, Tomino Y. TWEAK/Fn14 system and crescent formation in IgA nephropathy. BMC Nephrol. 2015;16:27 pubmed publisher

Rojo Martinez G, Maymó Masip E, Rodriguez M, Solano E, Goday A, Soriguer F, et al. Serum sCD163 levels are associated with type 2 diabetes mellitus and are influenced by coffee and wine consumption: results of the Di@bet.es study. PLoS ONE. 2014;9:e101250 pubmed publisher

Díaz López A, Bullo M, Chacon M, Estruch R, Vendrell J, Diez Espino J, et al. Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk. Cardiovasc Diabetol. 2014;13:51 pubmed publisher

Gaudineau B, Fougere M, Guaddachi F, Lemoine F, de la Grange P, Jauliac S. Lipocalin 2, the TNF-like receptor TWEAKR and its ligand TWEAK act downstream of NFAT1 to regulate breast cancer cell invasion. J Cell Sci. 2012;125:4475-86 pubmed publisher

Chen T, Guo Z, Li M, Li J, Jiao X, Zhang Y, et al. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura. Clin Exp Immunol. 2011;166:64-71 pubmed publisher